July 1, 2026 · Form 4 insider transaction
Casale Donn bought 898,456 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
25% of the shares subject to the option vest on June 1, 2027, and the remaining shares will vest monthly thereafter over three years.